Middlebury, CT, United States of America

Brendan F Laurenzi

USPTO Granted Patents = 16 

 

 

Average Co-Inventor Count = 4.1

ph-index = 5

Forward Citations = 180(Granted Patents)


Location History:

  • New Milford, CT (US) (2011 - 2017)
  • Middlebury, CT (US) (2017 - 2022)
  • Rutland, MA (US) (2022 - 2023)

Company Filing History:


Years Active: 2011-2024

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):

Title: Celebrating the Innovations of Brendan F. Laurenzi

Introduction: Brendan F. Laurenzi, an innovative inventor based in Middlebury, CT, has made significant contributions to the field of pulmonary drug delivery systems. With a remarkable portfolio of 16 patents, he has played a crucial role in enhancing medical technologies to improve patient care.

Latest Patents: Among his recent inventions is a dry powder drug delivery system, which encompasses a breath-powered inhaler designed to administer powdered formulations. This system includes a cartridge that can deliver a formulation consisting of diketopiperazine alongside various active ingredients such as small organic molecules, peptides, and proteins. Notably, this technology has potential applications for managing diseases such as diabetes and obesity, making it a pivotal innovation in the healthcare sector.

Career Highlights: Brendan currently holds a position at MannKind Corporation, where he actively engages in the development of cutting-edge medical devices and delivery systems. His breadth of experience and expertise in this domain has allowed him to contribute profoundly to his company's mission of improving patient outcomes through innovative technologies.

Collaborations: Throughout his career, Brendan has collaborated with notable colleagues, including Benoit Adamo and P. Spencer Kinsey. These collaborations have been instrumental in fostering an environment of creativity and progress, ultimately leading to the successful development of transformative healthcare solutions.

Conclusion: Brendan F. Laurenzi's dedication to innovation in the medical field is exemplified by his extensive patent portfolio and ongoing contributions at MannKind Corporation. His work, particularly in pulmonary drug delivery, highlights the importance of innovation in addressing critical health challenges faced by patients today.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…